Point-of-Care Monitoring of Anticoagulation Therapy, 1st Edition

This document provides guidance to users and manufacturers of point-of-care coagulation devices for monitoring heparin and warfarin anticoagulant therapy, and to ensure reliable results comparable to those obtained by routine clinical laboratory testing.

This document is available in electronic format only. 

Members: $54.00 → $153.00

Nonmembers: $180.00
Log in/sign up to see price and add to cart


Chairholder: Bruce H. Davis, MD and Samuel J. Machin, MB, ChB, FRCPath, FRCP

Date of Publication: July 1, 2004

Order Code PDF: POCT14AE
ISBN Number: 1-56238-540-2

Order Code Print: print not available

Edition: First

Pages: 48

POCT14 Additional Details

The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus standard for use in satisfying a regulatory requirement.  

This document was formerly sold under the code H49.